platinum has been researched along with Body Weight in 48 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (33.33) | 18.7374 |
| 1990's | 5 (10.42) | 18.2507 |
| 2000's | 13 (27.08) | 29.6817 |
| 2010's | 12 (25.00) | 24.3611 |
| 2020's | 2 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Bouvet, M; Clary, B; Han, Q; Higuchi, T; Hoffman, RM; Park, JH; Singh, SR; Sugisawa, N; Tan, Y; Yamamoto, J; Yoon, SN; Zhao, M | 1 |
| Chen, C; Fang, T; Han, W; Ren, L; Shu, L; Wang, H; Wang, Y; Ye, Z | 1 |
| Jevtić, VV; Matić, MM; Milošević, MD; Ognjanović, BI; Paunović, MG; Stanković, VD; Trifunović, SR | 1 |
| Ip, V; Liu, JJ; McKeage, MJ | 1 |
| Chikuma, M; Komeda, S; Odani, A; Suzuki, T; Takayama, H; Yamori, T | 1 |
| Kotb, R; Paquette, B; Sanche, L; Tippayamontri, T | 1 |
| Cougnon, M; Duranton, C; Melis, N; Mograbi, B; Rubera, I; Tauc, M | 1 |
| Chen, J; Gu, X; Liang, W; Sun, X; Wang, J | 1 |
| Cai, X; Cheng, Y; Ge, H; Huang, Q; Wang, C; Wang, X; Wang, Y; Xiao, J; Yan, W; Zhang, J; Zhang, Q | 1 |
| am Zehnhoff-Dinnesen, A; Ciarimboli, G; Deuster, D; Edemir, B; Holtkamp, M; Jürgens, H; Knief, A; Koepsell, H; Lanvers-Kaminsky, C; Pavenstädt, H; Schinkel, AH; Schlatter, E; Sperling, M | 1 |
| Fahmi, N; Sharma, K; Singh, RV | 1 |
| Blanco González, E; García Sar, D; Montes-Bayón, M; Sanz-Medel, A; Sierra Zapico, LM | 1 |
| Bronich, TK; Cohen, SM; Kabanov, AV; Nukolova, NV; Oberoi, HS | 1 |
| Kang, G; Li, Y; Liu, J; Peng, S; Wang, Y; Wu, J; Yang, Y; Zhang, X; Zhao, M; Zhong, X | 1 |
| El-Masry, SM; El-Sayed, IH | 1 |
| Al-Rikabi, AC; Daba, MH; Najjar, TA; Saad, SY | 1 |
| Begerow, J; Dunemann, L; Schrey, P; Wilhelm, M; Wittsiepe, J | 1 |
| Fujii, S; Kariya, M; Konishi, M; Mandai, M; Nanbu, K; Suzuki, A; Tabata, Y; Takakura, K | 1 |
| Cacini, W; Sarangarajan, R | 1 |
| Belani, CP; Fidias, P; Fossella, F; Gorbounova, V; Kaukel, E; Mattson, KV; Millward, M; Pereira, JR; Pluzanska, A; Ramlau, R; Szczesna, A; von Pawel, J | 1 |
| Barbara, C; Bocci, G; Danesi, R; Del Tacca, M; Di Paolo, A; Fioravanti, A; Natale, G; Orlandi, P | 1 |
| Lester, JF; Macbeth, FR | 1 |
| Dennis, C; Enquist, I; Go, N; Sawyer, PN; Wu, KT | 1 |
| Copley, MP; Litterst, CL; Osman, NM | 1 |
| Chapin, E; D'Agostino, RB; Lown, BA; Massaro, EJ; Morganti, JB | 1 |
| Elferink, F; Henzen-Logmans, SC; Pinedo, HM; Van der Poort, SE; Van der Vijgh, WJ | 1 |
| Bakchteeva, VT; Lavrova, EA; Natochin, YV; Reznik, LV | 1 |
| Cacini, W; Harden, EA; Skau, KA | 1 |
| Cacini, W; Di Iulio, D; Kishore, BK; Krane, CM; Menon, AG | 1 |
| Areberg, J; Johnsson, A; Mattsson, S; Norrgren, K; Wennerberg, J | 1 |
| Barrios, R; Hanigan, MH; Lieberman, MW; Lykissa, ED; Ou, CN; Townsend, DM | 1 |
| Cacini, W; Doran, JJ; Ecelbarger, CA; Kishore, BK; Sands, JM | 1 |
| Hanigan, MH; Townsend, DM | 1 |
| Orthoefer, JG; Pepelko, WE; Yang, YY | 1 |
| Feldman, RG; Garcia de Quevedo, M; Lewis, RW | 1 |
| Bellinger, LL; Bernardis, LL | 1 |
| DeWoskin, RS; Riviere, JE | 1 |
| Bader, R; Kirchgessner, M; Reichlmayr-Lais, AM | 1 |
| Hidaka, S; Inoue, T; Kiyozumi, M; Kojima, S; Tsuruoka, M | 1 |
| Brown, NS; Bulger, RE; Engineer, MS; Ho, DH; Newman, RA | 1 |
| Lelieveld, P; van der Vijgh, WJ; van Velzen, D | 1 |
| Frohman, LA; King, BM | 1 |
| Velasco, ME | 1 |
| Murphy, GP; Varkarakis, MJ | 1 |
| Welsch, CW | 1 |
| Gale, GR; Thompson, HS | 1 |
| Rosenberg, B; VanCamp, L | 1 |
| Davis, JE; Lewis, RW; Rubin, BA; Woods, JJ | 1 |
1 trial(s) available for platinum and Body Weight
| Article | Year |
|---|---|
Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life. A randomized controlled trial.
Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Female; Humans; Lung Neoplasms; Male; Middle Aged; Pain; Patient Compliance; Platinum; Prospective Studies; Psychomotor Performance; Quality of Life; Sickness Impact Profile; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine | 2006 |
47 other study(ies) available for platinum and Body Weight
| Article | Year |
|---|---|
Oral recombinant methioninase combined with oxaliplatinum and 5-fluorouracil regressed a colon cancer growing on the peritoneal surface in a patient-derived orthotopic xenograft mouse model.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carbon-Sulfur Lyases; Cell Proliferation; Colonic Neoplasms; Fluorescence; Fluorouracil; Humans; Mice, Nude; Peritoneum; Platinum; Recombinant Proteins; Time Factors; Treatment Outcome; Xenograft Model Antitumor Assays | 2019 |
Niacin-ligated platinum(iv)-ruthenium(ii) chimeric complexes synergistically suppress tumor metastasis and growth with potentially reduced toxicity in vivo.
Topics: Animals; Antineoplastic Agents; Body Weight; Cell Line, Tumor; Cell Proliferation; Cisplatin; Coordination Complexes; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Niacin; Platinum; Ruthenium; Structure-Activity Relationship | 2020 |
Evaluation of Toxic Effects of Novel Platinum (IV) Complexes in Female Rat Liver: Potential Protective Role of Resveratrol.
Topics: Animals; Antioxidants; Body Weight; Cisplatin; Eating; Estradiol; Female; Liver; Male; Oxidation-Reduction; Oxidative Stress; Platinum; Rats; Rats, Wistar; Resveratrol; Sex Factors | 2021 |
Evaluation of effects of copper histidine on copper transporter 1-mediated accumulation of platinum and oxaliplatin-induced neurotoxicity in vitro and in vivo.
Topics: Adenosine Triphosphatases; Animals; Body Weight; Cation Transport Proteins; Copper; Copper Transporter 1; Copper-Transporting ATPases; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Female; Ganglia, Spinal; Heavy Metal Poisoning, Nervous System; HEK293 Cells; Histidine; Humans; Organometallic Compounds; Organoplatinum Compounds; Oxaliplatin; Platinum; Rats; Transfection | 2013 |
Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
Topics: Animals; Antineoplastic Agents; Body Weight; Cell Death; Cell Line, Tumor; Humans; Mice; Mice, Nude; Molecular Conformation; Organoplatinum Compounds; Pancreatic Neoplasms; Platinum; Treatment Outcome; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
Efficacy of cisplatin and Lipoplatin™ in combined treatment with radiation of a colorectal tumor in nude mouse.
Topics: Animals; Apoptosis; Body Weight; Cell Nucleus; Chemoradiotherapy; Cisplatin; Colorectal Neoplasms; Combined Modality Therapy; HCT116 Cells; Humans; Male; Mice; Mice, Nude; Platinum; Time Factors; Treatment Outcome; Xenograft Model Antitumor Assays | 2013 |
Role of CFTR in oxidative stress and suicidal death of renal cells during cisplatin-induced nephrotoxicity.
Topics: Animals; Benzoates; Biomarkers; Body Weight; Caspase 3; Cell Death; Cell Line, Tumor; Cell Survival; Cisplatin; Cystic Fibrosis Transmembrane Conductance Regulator; DNA Adducts; Enzyme Activation; Female; Glutathione; Humans; Intracellular Space; Kidney; Kidney Diseases; Kidney Tubules, Proximal; Mice; Oxidative Stress; Platinum; Rats; Rats, Wistar; Reactive Oxygen Species; Thiazolidines | 2013 |
Efficacy and toxicity of cisplatin liposomes modified with polyethylenimine.
Topics: Animals; Antineoplastic Agents; Body Weight; Cell Line, Tumor; Cell Survival; Cisplatin; Drug Compounding; Drug Delivery Systems; Exocytosis; Humans; Indicators and Reagents; Kidney Diseases; Liposomes; Mice; Mice, Inbred ICR; Neoplasm Transplantation; Platinum; Polyethyleneimine | 2014 |
Trifolium-like Platinum Nanoparticle-Mediated Photothermal Therapy Inhibits Tumor Growth and Osteolysis in a Bone Metastasis Model.
Topics: Animals; Biocompatible Materials; Body Weight; Bone Neoplasms; Cell Line; Cell Line, Tumor; HeLa Cells; Humans; Imaging, Three-Dimensional; Infrared Rays; Metal Nanoparticles; Mice; Mice, Nude; Microscopy, Electron, Transmission; Neoplasm Metastasis; Neoplasms; NIH 3T3 Cells; Osteolysis; Photochemistry; Phototherapy; Platinum; Platinum Compounds; Povidone; Tomography, X-Ray Computed; Trifolium; X-Ray Microtomography | 2015 |
Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions.
Topics: Animals; Auditory Threshold; Blood Urea Nitrogen; Body Weight; Cation Transport Proteins; Cell Line, Tumor; Cisplatin; Cochlea; Copper Transporter 1; Ear Diseases; Glucose; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Male; Mice; Mice, Knockout; Organic Cation Transport Proteins; Organic Cation Transporter 2; Platinum; Protective Agents; Stria Vascularis | 2010 |
Palladium(II) and platinum(II) derivatives of benzothiazoline ligands: Synthesis, characterization, antimicrobial and antispermatogenic activity.
Topics: Animals; Anti-Infective Agents; Antispermatogenic Agents; Bacteria; Benzothiazoles; Body Weight; Cholesterol; Electrons; Fertility; Fructose; Fungi; Glycogen; Ligands; Magnetic Resonance Spectroscopy; Male; Microbial Sensitivity Tests; N-Acetylneuraminic Acid; Organ Size; Palladium; Platinum; Rats; Rats, Wistar; Spectrophotometry, Infrared; Sperm Motility | 2011 |
Reduction of cisplatin-induced nephrotoxicity in vivo by selenomethionine: the effect on cisplatin-DNA adducts.
Topics: Animals; Antineoplastic Agents; Antioxidants; Body Weight; Cisplatin; Creatinine; DNA Adducts; Drug Interactions; Kidney; Kidney Diseases; Liver; Male; Models, Molecular; Platinum; Rats; Rats, Wistar; Selenium; Selenomethionine | 2011 |
Folate-decorated nanogels for targeted therapy of ovarian cancer.
Topics: Animals; Antineoplastic Agents; Biological Availability; Body Weight; Cell Line, Tumor; Cell Survival; Cisplatin; Doxorubicin; Drug Delivery Systems; Endocytosis; Female; Folic Acid; Humans; Hydrogels; Hydrogen-Ion Concentration; Inhibitory Concentration 50; Light; Mice; Mice, Nude; Microscopy, Atomic Force; Nanoparticles; Osmolar Concentration; Ovarian Neoplasms; Particle Size; Platinum; Polyethylene Glycols; Polymethacrylic Acids; Scattering, Radiation; Static Electricity; Surface Properties; Survival Analysis; Water; Xenograft Model Antitumor Assays | 2011 |
Novel potassium N-[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxylhex-1-yl]-L-amino acid dichloroplatinates(II) with high anti-tumor activity and low side reaction.
Topics: Animals; Antineoplastic Agents; Body Weight; Cell Proliferation; Feces; HeLa Cells; Humans; Male; Mice; Mice, Inbred ICR; Organoplatinum Compounds; Platinum; Survival Analysis; Tissue Distribution; Xenograft Model Antitumor Assays | 2012 |
Protection against cisplatin-induced nephrotoxicity by Cu(II)2(3,5-diisopropylsalicylate)4.
Topics: Animals; Antineoplastic Agents; Antioxidants; Body Weight; Catalase; Cisplatin; Creatinine; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Kidney; Male; Platinum; Rats; Salicylates; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Urea | 2003 |
Inhibition of nitric oxide synthase aggravates cisplatin-induced nephrotoxicity: effect of 2-amino-4-methylpyridine.
Topics: Animals; Antineoplastic Agents; Body Weight; Cisplatin; Drug Synergism; Injections, Intraperitoneal; Kidney; Male; Necrosis; Nephritis, Interstitial; Nitric Oxide Synthase; Picolines; Platinum; Rats; Rats, Wistar | 2002 |
Dietary intake of platinum and gold by children from Germany using duplicate portion sampling.
Topics: Body Weight; Child; Child Nutritional Physiological Phenomena; Child, Preschool; Diet; Eating; Environmental Exposure; Environmental Pollutants; Female; Food Analysis; Food Contamination; Germany; Gold; Humans; Infant; Male; Platinum | 2003 |
In vivo anti-tumor effect through the controlled release of cisplatin from biodegradable gelatin hydrogel.
Topics: Animals; Antineoplastic Agents; Biological Availability; Blood Urea Nitrogen; Body Weight; Cisplatin; Delayed-Action Preparations; Drug Implants; Female; Fibrosarcoma; Gelatin; Glutaral; Hemoglobins; Hydrogels; Kinetics; Leukocyte Count; Mice; Microscopy, Electron, Scanning; Platelet Count; Platinum; Spectrophotometry, Atomic; Survival Rate; Water | 2003 |
Early onset of cisplatin-induced nephrotoxicity in streptozotocin-diabetic rats treated with insulin.
Topics: Animals; Blood Glucose; Blood Urea Nitrogen; Body Weight; Cisplatin; Diabetes Mellitus, Experimental; Drug Administration Schedule; Glycated Hemoglobin; Hyperglycemia; Injections, Intraperitoneal; Injections, Subcutaneous; Insulin, Isophane; Kidney; Kidney Diseases; Male; Platinum; Rats; Rats, Sprague-Dawley; Streptozocin; Time Factors | 2004 |
In vitro and in vivo antitumour effects of novel, orally active bile acid-conjugated platinum complexes on rat hepatoma.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Behavior, Animal; Bile Acids and Salts; Body Weight; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Liver Neoplasms, Experimental; Male; Molecular Structure; Motor Activity; Organoplatinum Compounds; Platinum; Rats; Rats, Sprague-Dawley; Survival Rate; Time Factors | 2006 |
Quality of life assessment in the TAX 326 study.
Topics: Activities of Daily Living; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma, Non-Small-Cell Lung; Cisplatin; Docetaxel; Female; Humans; Lung Neoplasms; Male; Middle Aged; Pain; Patient Compliance; Platinum; Psychomotor Performance; Quality of Life; Sickness Impact Profile; Taxoids; Treatment Outcome; Vinblastine; Vinorelbine | 2007 |
Effects of electric currents and interfacial potentials on wound healing.
Topics: Animals; Body Weight; Electricity; Electrophysiology; Platinum; Rabbits; Stainless Steel; Sutures; Wound Healing | 1967 |
Effects of the diuretics mannitol or acetazolamide on nephrotoxicity and physiological disposition of cisplatin in rats.
Topics: Acetazolamide; Animals; Blood Urea Nitrogen; Body Weight; Cisplatin; Kidney; Male; Mannitol; Platinum; Rats; Rats, Inbred F344 | 1984 |
Effects on the development of offspring of female mice exposed to platinum sulfate or sodium hexachloroplatinate during pregnancy or lactation.
Topics: Analysis of Variance; Animals; Behavior, Animal; Body Weight; Cisplatin; Female; Fetus; Lactation; Male; Mice; Mice, Inbred ICR; Platinum; Pregnancy | 1984 |
Influence of hydrolysis products of aqua(1,1-bis(aminomethyl)cyclohexane)sulfatoplatinum(II) on toxicity in rats.
Topics: Animals; Body Weight; Cisplatin; Creatinine; Dose-Response Relationship, Drug; Hydrolysis; Kidney; Male; Organoplatinum Compounds; Platinum; Proteinuria; Rats; Rats, Inbred Strains; Solutions | 1984 |
Renal function and renal platinum content in uninephrectomized rats following cisplatin administration.
Topics: Animals; Body Weight; Cisplatin; Female; Kidney; Nephrectomy; Organ Size; Platinum; Rats; Rats, Wistar; Spectrophotometry, Atomic; Time Factors | 1993 |
Reduced renal accumulation and toxicity of cisplatin in experimental galactosemia.
Topics: Animals; Blood Glucose; Blood Urea Nitrogen; Body Weight; Cisplatin; Diabetes Mellitus, Experimental; Diuresis; Galactosemias; Kidney Cortex; Kidney Diseases; Male; Platinum; Rats; Rats, Sprague-Dawley | 1993 |
Expression of renal aquaporins 1, 2, and 3 in a rat model of cisplatin-induced polyuria.
Topics: Animals; Antineoplastic Agents; Aquaporin 1; Aquaporin 2; Aquaporin 3; Aquaporin 6; Aquaporins; Blood Urea Nitrogen; Blotting, Northern; Body Weight; Cisplatin; Disease Models, Animal; Gene Expression; Immunoblotting; Kidney Tubules, Collecting; Kidney Tubules, Proximal; Male; Platinum; Polyuria; Rats; Rats, Sprague-Dawley; RNA, Messenger; Urinalysis; Vasopressins | 2000 |
Antitumor effect of radioactive cisplatin (191Pt) on nude mice.
Topics: Animals; Antineoplastic Agents; Body Weight; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Drug Combinations; Drug Screening Assays, Antitumor; Female; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Platinum; Radiation-Sensitizing Agents; Radioisotopes; Transplantation, Heterologous | 2001 |
Gamma-glutamyl transpeptidase-deficient mice are resistant to the nephrotoxic effects of cisplatin.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Blood Urea Nitrogen; Body Weight; Cisplatin; Creatinine; Drug Resistance; Female; gamma-Glutamyltransferase; Kidney; Mice; Mice, Inbred C57BL; Mice, Knockout; Platinum; Reference Values | 2001 |
Expression of salt and urea transporters in rat kidney during cisplatin-induced polyuria.
Topics: Animals; Antineoplastic Agents; Blood Urea Nitrogen; Blotting, Northern; Body Weight; Carrier Proteins; Cisplatin; Immunoblotting; Kidney; Male; Membrane Glycoproteins; Membrane Transport Proteins; Platinum; Polyuria; Rats; Rats, Sprague-Dawley; Sodium Chloride; Urea Transporters; Urine | 2001 |
Inhibition of gamma-glutamyl transpeptidase or cysteine S-conjugate beta-lyase activity blocks the nephrotoxicity of cisplatin in mice.
Topics: Aminooxyacetic Acid; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Blood Urea Nitrogen; Body Weight; Carbon-Sulfur Lyases; Cisplatin; Enzyme Inhibitors; gamma-Glutamyltransferase; Isoxazoles; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Platinum; Survival Analysis | 2002 |
Effects of 90 days exposure to catalytically treated automobile exhaust in rats.
Topics: Animals; Body Weight; Catalysis; Diet; Hydrogen-Ion Concentration; Lung Diseases; Lung Volume Measurements; Male; Organ Size; Palladium; Platinum; Rats; Time Factors; Vehicle Emissions | 1979 |
Leukopenia-induction capacity of 6-MP metallo-purine complexes in the rat.
Topics: Animals; Body Weight; Chelating Agents; Leukocyte Count; Leukopenia; Mercaptopurine; Palladium; Platinum; Rats; Time Factors | 1979 |
Production of weanling rat ventromedial and dorsomedial hypothalamic syndromes by electrolytic lesions with platinum-iridium electrodes.
Topics: Animals; Animals, Newborn; Body Weight; Electrodes; Feeding Behavior; Hypothalamus; Hypothalamus, Middle; Insulin; Iridium; Male; Obesity; Platinum; Prolactin; Rats | 1976 |
Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose diethyldithiocarbamate, but not mesna.
Topics: Animals; Blood Urea Nitrogen; Body Weight; Cisplatin; Copper; Creatinine; Ditiocarb; Female; Kidney; Kidney Diseases; Mesna; Platinum; Rats; Rats, Inbred F344; Zinc | 1992 |
Dose-response relationships of alimentary PtCl2 and PtCl4 in growing rats.
Topics: Animals; Body Weight; Diet; Dose-Response Relationship, Drug; Eating; Erythrocyte Count; Hematocrit; Hemoglobins; Male; Platinum; Platinum Compounds; Rats; Rats, Sprague-Dawley; Tissue Distribution | 1992 |
Protection against cis-diamminedichloroplatinum-induced nephrotoxicity in rats by N-benzyl-D-glucamine dithiocarbamate.
Topics: Animals; Aspartate Aminotransferases; Blood Urea Nitrogen; Body Weight; Carcinoma 256, Walker; Cisplatin; Female; Glycosuria; Kidney; Liver; Male; Platinum; Proteinuria; Random Allocation; Rats; Rats, Inbred Strains; Sorbitol; Thiocarbamates | 1991 |
A comparison of the effects of tetraplatin and cisplatin on renal function and gentamicin pharmacology in rats.
Topics: Animals; Antineoplastic Agents; Body Weight; Cisplatin; Gentamicins; Kidney; Kidney Function Tests; Kidney Tubules; Liver; Male; Organoplatinum Compounds; Platinum; Rats; Rats, Inbred F344; Spleen | 1989 |
Toxicology and pharmacokinetics of (1,1-bis(aminomethyl)cyclohexane)oxalatoplatinum(II) (TNO-38).
Topics: Animals; Antineoplastic Agents; Body Weight; Dogs; Drug Evaluation, Preclinical; Half-Life; Kinetics; Lethal Dose 50; Male; Mice; Organoplatinum Compounds; Platinum; Proteinuria; Rats | 1986 |
Nonirritative lesions of VMH: effects on plasma insulin, obesity, and hyperreactivity.
Topics: Animals; Blood Glucose; Body Weight; Electrodes, Implanted; Electroshock; Feeding and Eating Disorders; Female; Food Deprivation; Humans; Hyperkinesis; Hyperphagia; Insulin; Obesity; Platinum; Rats; Stainless Steel; Time Factors; Ventromedial Hypothalamic Nucleus | 1985 |
Opposite effects of platinum and stainless-steel lesions of the amygdala on gonadotropin secretion.
Topics: Amygdala; Animals; Body Weight; Electrodes; Estrus; Female; Gonadotropins; Male; Organ Size; Ovulation; Platinum; Pregnancy; Prostate; Rats; Secretory Rate; Seminal Vesicles; Stainless Steel; Testis; Thalamus | 1972 |
Prostatic effects of cis-diamine-chloroplatinum in the dog.
Topics: Acid Phosphatase; Alkaline Phosphatase; Amines; Animals; Antineoplastic Agents; Body Weight; Castration; Chlorides; Dogs; Estriol; Injections, Intravenous; Male; Organometallic Compounds; Osmolar Concentration; Platinum; Prostate; Protein Binding; Testosterone; Time Factors | 1972 |
Growth inhibition of rat mammary carcinoma induced by cis-platinum diamminodichloride-II.
Topics: Amines; Animals; Benz(a)Anthracenes; Body Weight; Castration; Chlorides; Cyclophosphamide; Diet; Female; Injections, Intraperitoneal; Mammary Neoplasms, Experimental; Platinum; Rats; Rats, Inbred Strains; Time Factors | 1971 |
cis-dichlorodiammineplatinum(II): hematopoietic effects in rats.
Topics: Adrenalectomy; Amines; Animals; Antineoplastic Agents; Body Weight; Bone Marrow; Chlorides; Erythrocytes; Hematocrit; Hematopoietic System; Hemoglobins; Lymphocytes; Male; Neutrophils; Organ Size; Platinum; Rats; Reticulocytes; Spleen; Thymus Gland; Time Factors | 1971 |
The successful regression of large solid sarcoma 180 tumors by platinum compounds.
Topics: Animals; Body Weight; Leukemia L1210; Mice; Neoplasm Transplantation; Platinum; Sarcoma 180 | 1970 |
Leukopenia induction capacity of 6-mercaptopurine platinum complex in the chick.
Topics: Animals; Body Weight; Chickens; Leukocyte Count; Leukopenia; Mercaptopurine; Platinum | 1968 |